Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 178 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of 177Lu-PSMA-617 In Metastatic Castrate-Resistant Prostate Cancer in Japan

 		Prostate Cancer Phase2 Japan

Study of MGY825 in Patients With Advanced Non-small Cell Lung Cancer

 		Non-small Cell Lung Cancer Phase1 United States
Spain
Japan
Germany
Switzerland
Korea, Republic of
View All

Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases

 		Myeloid Diseases Phase1 United States
Italy
Germany
France
Hong Kong
Spain
Singapore
View All

Phase I/II Study of Rapcabtagene Autoleucel in CLL, 3L+ DLBCL, ALL and 1L HR LBCL

 		Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Diffuse Large B-cell Lymphoma, Acute Lymphoblastic Leukemia, Large B-cell Lymphoma Phase1, Phase2 United States
Spain
Italy
Japan
Germany
France
Australia
Austria
View All

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

 		Mesothelioma Phase1 United States
Spain
Japan
Germany
United Kingdom
Australia
Italy
Canada
Netherlands
France
Switzerland
View All

Exploring the Profiles of RMS Patients on Ofatumumab or Ocrelizumab in a Real-World Setting in the Gulf

 		Relapsing Multiple Sclerosis United Arab Emirates
Oman

A 24-week Study Evaluating the Effectiveness and Safety of Lucentis® 0.2mg in Retinopathy of Prematurity Participants in China

 		Retinopathy of Prematurity China

Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V

 		Lupus Nephritis Phase2 Turkey
Israel
United States
China
Germany
Portugal
Hungary
Malaysia
Spain
France
Mexico
India
Hong Kong
Puerto Rico
Brazil
Singapore
View All

Long Term Observational Study to Collect in a Real-world populatIon Data on the Treatment Pattern of secukinumAb in Adult Patients With Moderate to Severe Hidradenitis Suppurativa.

 		Hidradenitis Suppurativa Germany

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

 		Chronic Rhinosinusitis With Nasal Polyps Korea, Republic of